Research comparison
CJC-1295 vs. ipamorelin
Two routes to growth hormone release: Mod GRF 1-29 acts at the GHRH receptor, ipamorelin selectively at the ghrelin receptor (GHS-R1a). Because they act at different receptors, studies often examine them together.
| Property | CJC-1295 No DAC (Mod GRF 1-29) | Ipamorelin |
|---|---|---|
| Profile | Modified GRF(1–29), a tetrasubstituted fragment of growth hormone-releasing hormone without drug affinity complex (DAC). | Selective agonist of the ghrelin receptor (GHS-R1a) from the group of pentapeptide GH secretagogues. |
| Sequence | Y-(D-A)-DAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 (Mod GRF 1-29: D-Ala2, Gln8, Ala15, Leu27) | Aib-His-D-2Nal-D-Phe-Lys-NH2 |
| Length | – | – |
| Formula | – | C₃₈H₄₉N₉O₅ |
| Molar mass | – | 711.9 g/mol |
| CAS | – | 170851-70-4 |
| Purity (current batch, HPLC) | 99.47 % | 99.77 % |
| Price per mg from | €5.00 | €5.00 |
In the range
For research and laboratory use only. Not for use in humans or animals. The data summarises literature and lab reports; it is not a recommendation for use.